(2019). A Comparison Between Dexlansoprazole Modified Release–Based And Lansoprazole-Based Nonbismuth Quadruple (Concomitant) Therapy For First-Line Helicobacter pylori Eradication: A Prospective Randomized Trial [Corrigendum]. Infect Drug Resist.
Citação norma Chicago"A Comparison Between Dexlansoprazole Modified Release–Based And Lansoprazole-Based Nonbismuth Quadruple (Concomitant) Therapy For First-Line Helicobacter Pylori Eradication: A Prospective Randomized Trial [Corrigendum]." Infect Drug Resist 2019.
Deismireacht MLA"A Comparison Between Dexlansoprazole Modified Release–Based And Lansoprazole-Based Nonbismuth Quadruple (Concomitant) Therapy For First-Line Helicobacter Pylori Eradication: A Prospective Randomized Trial [Corrigendum]." Infect Drug Resist 2019.